<DOC>
	<DOCNO>NCT00565812</DOCNO>
	<brief_summary>The objective 2-year study evaluate safety , tolerability disease modify efficacy SD 6010 , inhibitor inducible nitric oxide synthase ( iNOS ) , overweight obese subject knee osteoarthritis . The efficacy SD-6010 evaluate radiography use joint space narrow medial tibiofemoral compartment study knee primary endpoint .</brief_summary>
	<brief_title>A Long-Term , Placebo-Controlled X-Ray Study Investigating Safety Efficacy SD-6010 Subjects With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Subjects age &gt; = 40 year BMI &gt; = 25 &lt; = 40 kg/m2 In past , diagnosed knee OA Radiographic evidence OA study knee A diagnosis rheumatic disease Current condition study knee would confound efficacy Selected , traditional clinical safety laboratory parameter</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>knee Osteoarthritis Disease Modifying Osteoarthritis Drug</keyword>
</DOC>